AID Systems Help T2D Patients Regardless of C-Peptide Levels
Edited by Shrabasti Bhattacharya October 24, 2025 TOPLINE: Automated insulin delivery (AID) systems lowered A1c levels and increased percentage of time in range in adults with type 2 diabetes (T2D), regardless of C‑peptide level, a secondary analysis of a clinical trial showed. METHODOLOGY: The Centers for Medicare & Medicaid Services (CMS) requires a low C‑peptide level for insulin pump coverage unless a person […]
AID Systems Help T2D Patients Regardless of C-Peptide Levels Read More »
